Genemed Synthesis, Inc.

San Antonio, TX

UEI
W8CGAPUG5YK5
CAGE
55SG4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Manufacturer of Goods
  • Subcontinent Asian (Asian-Indian) American Owned
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4638 N Loop 1604 W #107, San Antonio, TX 78249, USA
Website
genemedsyn.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Genemed Synthesis, Inc. is a biotechnology research company that specializes in genetic engineering, synthesis, and peptide development. They provide custom peptide synthesis, catalog peptides, and other biotech products and services to federal agencies.

Genemed Synthesis has received several federal contract awards from the Department of Health and Human Services' National Institutes of Health to provide custom peptide synthesis services and catalog peptides to the National Institute on Drug Abuse. These were prime contract awards with no set-aside designations. Specific services provided include custom peptide synthesis with quoted order numbers, and catalog peptides identified by catalog numbers, names, lot numbers, weights, and purity levels. Award dates range between 2019-2022, with potential values from $10,925 to $23,895.

Quick answers

Is Genemed Synthesis, Inc. registered in SAM.gov?

Yes. Genemed Synthesis, Inc.'s SAM.gov registration is active through January 20, 2027.

What is Genemed Synthesis, Inc.'s most recent federal award?

Genemed Synthesis, Inc.'s most recent federal contract award is Genemed synthesis INC:1110196 [21-004523] (75N95021P00414), from National Institute on Drug Abuse (NIH), on August 3, 2021.

On GovTribe

See Genemed Synthesis, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors